-
Information
iCFO Information Booth How can we help? -
Entrepreneur
STRATAFOLIO Total Commercial Property Management Platform -
Entrepreneur
Nob Hill Therapeutics Pioneering Respiratory Patient Care -
Entrepreneur
PROOF Hard Ice Cream PROOF will be among the most highly recommended gourmet brands in the world -
Entrepreneur
Opus Genetics Envisioning a new future for patients with inherited retinal diseases -
EntrepreneurDigital Asset Management A coin for the future of crypto Investing
-
EntrepreneurAdlore Introducing SenLore - A Novel Device to Treat and Monitor Diabetic Foot Ulcers
-
EntrepreneurVasa Therapeutics Novel therapeutics for unmet medical needs in cardiovascular medicine
-
EntrepreneurSchmaltz Restaurant Group Spread Jewish Deli Goodness Everywhere
-
EntrepreneurNutr Changing the way we milk
-
EntrepreneurTorque3 Transformative Stroke Recovery
-
EntrepreneurSeekingSimple "Improved health through better processed food choices to address food related disease for 230M in the US and the resulting $1.1T problem for healthcare payors"
-
EntrepreneurKurve Therapeutics The Future of Systemic and Central Nervous System (CNS) Therapies - Bringing solutions to clinical unmet needs
-
EntrepreneurSoon Crypto Investing Automated & Easy
-
EntrepreneurGel Dynamics The only fully dynamic and continuous wheel balancing solution destined to reshape the trucking industry while contributing to a greener planet.
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Kevin Sill!
Join us next time to meet Kevin Sill!
About Welton Pharma
Welton Pharma was founded to develop pharmaceutical drug products. The company has in-licensed Lubrizol's Apisolex technology, invented by Welton Co-founders, to solubilize drugs that are not otherwise soluble in water. Welton will utilize this technology to provide novel, patent protected formulations that offer meaningful improvements to marketed drug products. Their lead product is anticipated to increase the response rate in cancer patients by 300% when compared to current standard of care.